CAS: 13701-70-7; Vanadium(ⅲ)Sulfate

专利信息

专利号:US-7932311-B2
优先权日:2005-12-23
标题 :Synthesis of particles in dendritic structures
发明人：AYMONIER CYRIL; CANSELL FRANCOIS; MECKING STEFAN; MOISAN SANDY; MARTINEZ VICTOR
权利人:CENTRE NAT RECH SCIENT
摘要:The invention relates to a method of preparing a particle-based composition, comprising: (i) bringing into contact a mixture comprising a dendritic structure and a metal compound precursor in a fluid, under temperature and pressure conditions such that the mixture is not soluble in the fluid; and (ii) chemically converting the metal compound precursor.

专利号:US-4517371-A
优先权日:1981-12-02
标题:Process for the synthesis of carboxylic anhydrides using a vanadium, phosphorus oxygen containing catalyst composition
发明人：YANG TAI-CHENG; RAO KRISHNA K; HUANG I-DER
权利人:EXXON RESEARCH ENGINEERING CO
摘要:A vanadium, phosphorus oxygen containing catalyst composition capable of partially oxidizing hydrocarbons (e.g., n-butane) to form a carboxylic anhydride (e.g., maleic anhydride), a process for preparing this catalyst, and a process for using this catalyst to form such anhydrides is disclosed. The catalyst composition is prepared by an organic heterogenous technique followed by a water treatment step and activation.

专利号:US-12187676-B2
优先权日:2019-03-29
标题 :Method for producing a catalyst for unsaturated carboxylic acid synthesis
发明人：ABE YOSHIMUNE; KANUKA NARIYASU; OKADA SHIGEKI
权利人:MITSUBISHI CHEM CORP
摘要:A method for producing a catalyst for unsaturated carboxylic acid synthesis is proposed. The method includes: obtaining a dried product by drying and heat-treating a starting material mixed liquid in which supply source compounds of respective catalyst component elements are integrated; and forming a catalyst precursor by supporting powder to be supported on a carrier in the form of a particle aggregate. The powder to be supported is either the dried product or obtained from the dried product. The method further includes calcining the catalyst precursor to form the catalyst. The mass loss rate of the powder to be supported at 300° C. is less than 5 percent by mass, and the difference between the mass loss rate of the powder at 370° C. and the mass loss rate of the powder at 300° C. is not less than 1 percent by mass and not more than 6 percent by mass.

专利号:US-2005085555-A1
优先权日:1997-08-21
标 题:Composition, synthesis and therapeutic applications of polyamines
发明人：MURPHY MICHAEL A; MALACHOWSKI MITCHELL R
摘要:This invention relates to a process of synthesis and composition of open chain (ring), closed ring, linear branched and or substituted polyamines, polyamine derived tyrosine phosphatase inhibitors and PPAR partial agonists/partial antagonists via a series of substitution reactions and optimizing the bioavailability and biological activities of the compounds. Polyamines prevent the toxicty of neutoxins and diabetogenic toxins including paraquat, methyphenyl pyridine radical, rotenone, diazoxide, streptozotocin and alloxan. These polyamines can be to treat neurological, cardiovascular, endocrine acquired and inherited mitochondrial DNA damage diseases and other disorders in mammalian subjects, and more specifically to the therapy of Parkinson's disease, Alzheimer's disease, Lou Gehrig's disease, Binswanger's disease, Olivopontine Cerebellar Degeneration, Lewy Body disease, Diabetes, Stroke, Atherosclerosis, Myocardial Ischemia, Cardiomyopathy, Nephropathy, Ischemia, Glaucoma, Presbycussis, Cancer, Osteoporosis, Rheumatoid Arthritis, Inflammatory Bowel Disease, Multiple Sclerosis and as Antidotes to Toxin Exposure.

专利号:US-2014057877-A1
优先权日:2002-12-18
标题:Therapeutic polyamine compositions and their synthesis
发明人：MURPHY MICHAEL A; MALACHOWSKI MITCHELL R
权利人:MURPHY MICHAEL A; MALACHOWSKI MITCHELL R
摘要:This invention relates to a process of synthesis and composition of open chain (ring), closed ring, linear branched and or substituted polyamines, polyamine derived tyrosine phosphatase inhibitors and PPAR partial agonists/partial antagonists via a series of substitution reactions and optimizing the bioavailability and biological activities of the compounds. Polyamines prevent the toxicity of neurotoxins and diabetogenic toxins including paraquat, methyphenyl pyridine radical, rotenone, diazoxide, streptozotocin and alloxan. These polyamines can be utilized to treat neurological, cardiovascular, endocrine acquired and inherited mitochondrial DNA damage diseases and other disorders in mammalian subjects, and more specifically to the therapy of Parkinson's disease, Alzheimer's disease, Lou Gehrig's disease, Binswanger's disease, Olivopontine Cerebellar Degeneration, Lewy Body disease, Diabetes, Stroke, Atherosclerosis, Myocardial Ischemia, Cardiomyopathy, Nephropathy, Ischemia, Glaucoma, Presbycussis, Cancer, Osteoporosis, Rheumatoid Arthritis, Inflammatory Bowel Disease, Multiple Sclerosis and as Antidotes to Toxin Exposure.

专利号:US-2022396593-A1
优先权日:2021-06-01
标题:Synthesis and characterization of vanadium complexes
发明人：CRANS DEBBIE C; MURAKAMI HEIDE; KOSTENKOVA KATERYNA
权利人:UNIV COLORADO STATE RES FOUND
摘要:The present application relates to preparation methods and uses of vanadium complexes providing a consistent and stable preparation. More specifically, the present application relates to preparation of vanadium citrate salts, phosphate salts, or combinations thereof, characterization of the properties of such salts, and methods using the same.